{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:55:47Z","timestamp":1790315747106,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T00:00:00Z","timestamp":1525910400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1038\/aps.2018.21","type":"journal-article","created":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T10:01:19Z","timestamp":1525946479000},"page":"1661-1669","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Nrf2 mediates the resistance of human A549 and HepG2 cancer cells to boningmycin, a new antitumor antibiotic, in vitro through regulation of glutathione levels"],"prefix":"10.1038","volume":"39","author":[{"given":"Hui-xian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-yang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,10]]},"reference":[{"key":"150_CR1","first-page":"465","volume":"28","author":"H Xu","year":"2003","unstructured":"Xu H, Yu L, Zhang X, Wang S. Isolation, purification and structure determination of boningmycin (Z-893). J Chin Antibiot 2003; 28: 465\u20137.","journal-title":"J Chin Antibiot"},{"key":"150_CR2","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1097\/CAD.0b013e3283409bee","volume":"22","author":"N Gao","year":"2011","unstructured":"Gao N, Shang B, Zhang X, Shen C, Xu R, Xu H, et al. Potent antitumor actions of the new antibiotic boningmycin through induction of apoptosis and cellular senescence. Anticancer Drugs 2011; 22: 166\u201375.","journal-title":"Anticancer Drugs"},{"key":"150_CR3","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.3892\/ijo.2012.1668","volume":"41","author":"J  Chen","year":"2012","unstructured":"Chen J, Chen Y, He Q. Action of bleomycin is affected by bleomycin hydrolase but not by caveolin-1. Int J Oncol 2012; 41: 2245\u201352.","journal-title":"Int J Oncol"},{"key":"150_CR4","doi-asserted-by":"publisher","first-page":"4680","DOI":"10.1073\/pnas.96.8.4680","volume":"96","author":"DR Schwartz","year":"1999","unstructured":"Schwartz DR, Homanics GE, Hoyt DG, Klein E, Abernethy J, Lazo JS. The neutral cysteine protease bleomycin hydrolase is essential for epidermal integrity and bleomycin resistance. Proc Natl Acad Sci U S A 1999; 96: 4680\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"150_CR5","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3109\/10715762.2011.572969","volume":"45","author":"HC Yen","year":"2011","unstructured":"Yen HC, Li SH, Majima HJ, Huang YH, Chen CP, Liu CC, et al. Up-regulation of antioxidant enzymes and coenzyme Q(10) in a human oral cancer cell line with acquired bleomycin resistance. Free Radic Res 2011; 45: 707\u201316.","journal-title":"Free Radic Res"},{"key":"150_CR6","doi-asserted-by":"publisher","first-page":"6275","DOI":"10.1074\/jbc.M109.046151","volume":"285","author":"M Aouida","year":"2010","unstructured":"Aouida M, Poulin R, Ramotar D. The human carnitine transporter SLC22A16 mediates high affinity uptake of the anticancer polyamine analogue bleomycin-A5. J Biol Chem 2010; 285: 6275\u201384.","journal-title":"J Biol Chem"},{"key":"150_CR7","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nrc1547","volume":"5","author":"J Chen","year":"2005","unstructured":"Chen J, Stubbe J. Bleomycins: towards better therapeutics. Nat Rev Cancer 2005; 5: 102\u201312.","journal-title":"Nat Rev Cancer"},{"key":"150_CR8","first-page":"4453","volume":"62","author":"G Sanz","year":"2002","unstructured":"Sanz G, Mir L, Jacquemin-Sablon A. Bleomycin resistance in mammalian cells expressing a genetic suppressor element derived from the SRPK1 gene. Cancer Res 2002; 62: 4453\u20138.","journal-title":"Cancer Res"},{"key":"150_CR9","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.tips.2013.04.005","volume":"34","author":"T Suzuki","year":"2013","unstructured":"Suzuki T, Motohashi H, Yamamoto M. Toward clinical application of the Keap1-Nrf2 pathway. Trends Pharmacol Sci 2013; 34: 340\u20136.","journal-title":"Trends Pharmacol Sci"},{"key":"150_CR10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/ncb2021","volume":"12","author":"M Komatsu","year":"2010","unstructured":"Komatsu M, Kurokawa H, Waguri S, Taguchi K, Kobayashi A, Ichimura Y, et al. The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat Cell Biol 2010; 12: 213\u201323.","journal-title":"Nat Cell Biol"},{"key":"150_CR11","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.molcel.2009.04.029","volume":"34","author":"W Chen","year":"2009","unstructured":"Chen W, Sun Z, Wang XJ, Jiang T, Huang Z, Fang D, et al. Direct interaction between Nrf2 and p21(Cip1\/WAF1) upregulates the Nrf2-mediated antioxidant response. Mol Cell 2009; 34: 663\u201373.","journal-title":"Mol Cell"},{"key":"150_CR12","doi-asserted-by":"publisher","first-page":"39776","DOI":"10.1074\/jbc.M605707200","volume":"281","author":"R Faraonio","year":"2006","unstructured":"Faraonio R, Vergara P, Di Marzo D, Pierantoni MG, Napolitano M, Russo T, et al. p53 suppresses the Nrf2-dependent transcription of antioxidant response genes. J Biol Chem 2006; 281: 39776\u201384.","journal-title":"J Biol Chem"},{"key":"150_CR13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.freeradbiomed.2015.06.006","volume":"88","author":"T Suzuki","year":"2015","unstructured":"Suzuki T, Yamamoto M. Molecular basis of the Keap1-Nrf2 system. Free Radic Biol Med 2015; 88: 93\u2013100.","journal-title":"Free Radic Biol Med"},{"key":"150_CR14","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature10189","volume":"475","author":"GM DeNicola","year":"2011","unstructured":"DeNicola GM, Karreth FA, Humpton TJ, Gopinathan A, Wei C, Frese K, et al. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 2011; 475: 106\u20139.","journal-title":"Nature"},{"key":"150_CR15","doi-asserted-by":"publisher","first-page":"7430","DOI":"10.1158\/0008-5472.CAN-14-1439","volume":"74","author":"S Tao","year":"2014","unstructured":"Tao S, Wang S, Moghaddam SJ, Ooi A, Chapman E, Wong PK, et al. Oncogenic KRAS confers chemoresistance by upregulating NRF2. Cancer Res 2014; 74: 7430\u201341.","journal-title":"Cancer Res"},{"key":"150_CR16","doi-asserted-by":"publisher","first-page":"3423","DOI":"10.1158\/1078-0432.CCR-08-2822","volume":"15","author":"S Homma","year":"2009","unstructured":"Homma S, Ishii Y, Morishima Y, Yamadori T, Matsuno Y, Haraguchi N, et al. Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer. Clin Cancer Res 2009; 15: 3423\u201332.","journal-title":"Clin Cancer Res"},{"key":"150_CR17","doi-asserted-by":"publisher","first-page":"7975","DOI":"10.1158\/0008-5472.CAN-08-1401","volume":"68","author":"A Singh","year":"2008","unstructured":"Singh A, Boldin-Adamsky S, Thimmulappa RK, Rath SK, Ashush H, Coulter J, et al. RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy. Cancer Res 2008; 68:7975\u201384.","journal-title":"Cancer Res"},{"key":"150_CR18","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1089\/ars.2010.3219","volume":"13","author":"A Singh","year":"2010","unstructured":"Singh A, Bodas M, Wakabayashi N, Bunz F, Biswal S. Gain of Nrf2 function in non-small-cell lung cancer cells confers radioresistance. Antioxid Redox Signal 2010; 13: 1627\u201337.","journal-title":"Antioxid Redox Signal"},{"key":"150_CR19","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1073\/pnas.1014275108","volume":"108","author":"D Ren","year":"2011","unstructured":"Ren D, Villeneuve NF, Jiang T, Wu T, Lau A, Toppin HA, et al. Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism. Proc Natl Acad Sci U S A 2011; 108: 1433\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"150_CR20","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/j.freeradbiomed.2011.03.008","volume":"50","author":"X Tang","year":"2011","unstructured":"Tang X, Wang H, Fan L, Wu X, Xin A, Ren H, et al. Luteolin inhibits Nrf2 leading to negative regulation of the Nrf2\/ARE pathway and sensitization of human lung carcinoma A549 cells to therapeutic drugs. Free Radic Biol Med 2011; 50: 1599\u2013609.","journal-title":"Free Radic Biol Med"},{"key":"150_CR21","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.freeradbiomed.2014.11.003","volume":"78","author":"A Olayanju","year":"2015","unstructured":"Olayanju A, Copple IM, Bryan HK, Edge GT, Sison RL, Wong MW, et al. Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity-implications for therapeutic targeting of Nrf2. Free Radic Biol Med 2015; 78: 202\u201312.","journal-title":"Free Radic Biol Med"},{"key":"150_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1465-9921-11-31","volume":"11","author":"N Kikuchi","year":"2010","unstructured":"Kikuchi N, Ishii Y, Morishima Y, Yageta Y, Haraguchi N, Itoh K, et al. Nrf2 protects against pulmonary fibrosis by regulating the lung oxidant level and Th1\/Th2 balance. Respir Res 2010; 11: 31.","journal-title":"Respir Res"},{"key":"150_CR23","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.mrgentox.2010.01.006","volume":"696","author":"G Pujari","year":"2010","unstructured":"Pujari G, Sarma A, Chatterjee A. The influence of reduced glutathione on chromosome damage induced by X-rays or heavy ion beams of different LETs and on the interaction of DNA lesions induced by radiations and bleomycin. Mutat Res 2010; 696: 154\u20139.","journal-title":"Mutat Res"},{"key":"150_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.mrgentox.2009.02.001","volume":"675","author":"G Pujari","year":"2009","unstructured":"Pujari G, Berni A, Palitti F, Chatterjee A. Influence of glutathione levels on radiation-induced chromosomal DNA damage and repair in human peripheral lymphocytes. Mutat Res 2009; 675: 23\u20138.","journal-title":"Mutat Res"},{"key":"150_CR25","doi-asserted-by":"publisher","first-page":"939","DOI":"10.3892\/or.2013.2484","volume":"30","author":"Y Chen","year":"2013","unstructured":"Chen Y, Xu R, Chen J, Li X, He Q. Cleavage of bleomycin hydrolase by caspase-3 during apoptosis. Oncol Rep 2013; 30: 939\u201344.","journal-title":"Oncol Rep"},{"key":"150_CR26","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1016\/j.bbagen.2012.09.008","volume":"1830","author":"SC Lu","year":"2013","unstructured":"Lu SC. Glutathione synthesis. Biochim Biophys Acta 2013; 1830: 3143\u201353.","journal-title":"Biochim Biophys Acta"},{"key":"150_CR27","doi-asserted-by":"publisher","first-page":"4592","DOI":"10.1073\/pnas.072067999","volume":"99","author":"LH Einhorn","year":"2002","unstructured":"Einhorn LH. Curing metastatic testicular cancer. Proc Natl Acad Sci U S A 2002; 99: 4592\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"150_CR28","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1056\/NEJMra1407550","volume":"371","author":"NH Hanna","year":"2014","unstructured":"Hanna NH, Einhorn LH. Testicular cancer-discoveries and updates. N Engl J Med 2014; 371: 2005\u201316.","journal-title":"N Engl J Med"},{"key":"150_CR29","doi-asserted-by":"publisher","first-page":"326ra20","DOI":"10.1126\/scitranslmed.aad7785","volume":"8","author":"O Burgy","year":"2016","unstructured":"Burgy O, Wettstein G, Bellaye PS, Decologne N, Racoeur C, Goirand F, et al. Deglycosylated bleomycin has the antitumor activity of bleomycin without pulmonary toxicity. Sci Transl Med 2016; 8: 326ra20.","journal-title":"Sci Transl Med"},{"key":"150_CR30","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/bjc.1998.628","volume":"78","author":"AB Simpson","year":"1998","unstructured":"Simpson AB, Paul J, Graham J, Kaye SB. Fatal bleomycin pulmonary toxicity in the west of Scotland 1991-95: a review of patients with germ cell tumours. Br J Cancer 1998; 78: 1061\u20136.","journal-title":"Br J Cancer"},{"key":"150_CR31","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1200\/JCO.2007.14.1606","volume":"26","author":"EC de Haas","year":"2008","unstructured":"de Haas EC, Zwart N, Meijer C, Nuver J, Boezen HM, Suurmeijer AJ, et al. Variation in bleomycin hydrolase gene is associated with reduced survival after chemotherapy for testicular germ cell cancer. J Clin Oncol 2008; 26: 1817\u201323.","journal-title":"J Clin Oncol"},{"key":"150_CR32","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.cell.2015.01.043","volume":"160","author":"N Oshimori","year":"2015","unstructured":"Oshimori N, Oristian D, Fuchs E. TGF-\u03b2 promotes heterogeneity and drug resistance in squamous cell carcinoma. Cell 2015; 160: 963\u201376.","journal-title":"Cell"},{"key":"150_CR33","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.cell.2016.06.056","volume":"166","author":"II Chio","year":"2016","unstructured":"Chio II, Jafarnejad SM, Ponz-Sarvise M, Park Y, Rivera K, Palm W, et al. NRF2 promotes tumor maintenance by modulating mRNA translation in pancreatic cancer. Cell 2016; 166: 963\u201376.","journal-title":"Cell"},{"key":"150_CR34","doi-asserted-by":"publisher","first-page":"7430","DOI":"10.1158\/0008-5472.CAN-14-1439","volume":"74","author":"S Tao","year":"2014","unstructured":"Tao S, Wang S, Moghaddam SJ, Ooi A, Chapman E, Wong PK, et al. Oncogenic KRAS confers chemoresistance by upregulating NRF2. Cancer Res 2014; 74: 7430\u201341.","journal-title":"Cancer Res"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/aps201821","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps201821.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/aps.2018.21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/aps201821.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:37:30Z","timestamp":1684413450000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/aps201821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,10]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["150"],"URL":"https:\/\/doi.org\/10.1038\/aps.2018.21","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,10]]},"assertion":[{"value":"30 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}